Zurück geht es hier Grüezi! Sie wurden auf finanzen.ch, unser Portal für Schweizer Anleger, weitergeleitet.  Zurück geht es hier.

Bullish Aktie 147231164 / KYG169101204

29.10.2025 23:00:35

Tron Shows Bullish Divergence As Active Addresses Surge To 6.2M - Network Demand Explodes

Tron (TRX) is consolidating this week as the broader crypto market braces for the upcoming US Federal Reserve decision on interest rates and quantitative tightening (QT). Investors are treading carefully, with uncertainty surrounding whether the Fed will maintain its restrictive stance or pivot toward easing—an outcome that could shift liquidity flows across digital assets. Despite the cautious market mood, on-chain data from CryptoQuant highlights a powerful surge in Tron’s network activity that stands out from the rest of the market.On October 27, 2025, Tron flagged one of its most significant on-chain events to date. The number of daily active addresses skyrocketed from a steady baseline of roughly 3.5 million to an astonishing 6.23 million, marking the second-highest activity ever recorded in the network’s history. This massive uptick underscores a sharp increase in network demand and utility, suggesting that users are actively engaging with decentralized applications and stablecoin transfers within the Tron ecosystem.While price action remains in a consolidation phase, this sudden burst in on-chain participation paints a different picture—a growing fundamental strength that could position Tron as one of the few networks expanding its real-world activity amid macroeconomic uncertainty.Fundamentals Show Strength As Tron Price CorrectsAccording to a recent CryptoOnchain report published on CryptoQuant, Tron’s latest on-chain surge reveals an intriguing dynamic between network activity and market price. What makes this event particularly compelling is the clear bullish divergence it forms. While Tron’s fundamentals are strengthening, its price has been steadily declining—a pattern that often precedes a reversal.Specifically, the number of daily active addresses jumped from 3.5 million to 6.23 million on October 27, 2025, marking one of the network’s most active days ever. Meanwhile, TRX has been in a soft downtrend since August, slipping from a high near $0.36 to roughly $0.29. This divergence—rising on-chain engagement amid falling prices—suggests that market participants are underpricing Tron’s growing real-world utility.Historically, such divergences between on-chain strength and price weakness have often acted as leading indicators for trend shifts. In Tron’s case, the data implies that network demand and user adoption are increasing faster than market sentiment reflects.Analysts point to several possible catalysts behind this activity, including new decentralized application (dApp) launches, higher stablecoin transaction volumes, and effective user acquisition campaigns across the ecosystem.The key factor now is sustainability. If this elevated level of activity holds through the coming weeks, it would confirm that Tron’s network growth is structural rather than temporary. Such validation could lay the groundwork for a significant bullish reversal, especially if macro conditions—like the Federal Reserve’s rate and QT decisions—shift toward easing, boosting liquidity across risk assets.TRX Tests Key Moving Average As Bulls Defend SupportTron’s (TRX) price is showing signs of consolidation around the $0.29–$0.30 range after an extended pullback from the August high of $0.36. The daily chart reveals that TRX has now reached the 200-day moving average (red line) — a key technical support that has historically served as a major inflection point for trend reversals. The asset briefly dipped below this level earlier in the week but has since recovered slightly, suggesting that buyers are attempting to stabilize momentum.The 50-day (blue) and 100-day (green) moving averages are trending lower, reflecting short-term weakness after months of bullish structure. However, holding above the 200-day MA could mark the beginning of a base formation before a potential rebound. A confirmed close below this level, by contrast, would open the door for a deeper retracement toward $0.27 or even $0.25, where previous accumulation zones exist.Trading volume remains moderate, hinting that the market is in a wait-and-see mode ahead of the US Federal Reserve’s interest rate and QT decision. If broader market sentiment turns risk-on and on-chain activity remains elevated, TRX could soon attempt a recovery toward $0.32–$0.33, reclaiming its medium-term trend.Featured image from ChatGPT, chart from TradingView.comWeiter zum vollständigen Artikel bei NewsBTC

Analysen zu Surge Holdings Inc Registered Shs

  • Alle
  • Kaufen
  • Hold
  • Verkaufen
  • ?
Zu diesem Datensatz liegen uns leider keine Daten vor.
Eintrag hinzufügen

Erfolgreich hinzugefügt!. Zu Portfolio/Watchlist wechseln.

Es ist ein Fehler aufgetreten!

Kein Portfolio vorhanden. Bitte zusätzlich den Namen des neuen Portfolios angeben. Keine Watchlisten vorhanden. Bitte zusätzlich den Namen der neuen Watchlist angeben.

CHF
Hinzufügen

Mittwoch um 18 Uhr live: Die Illusion der Erinnerung - Wie du Denkfehler im Trading vermeidest

Erfahrung ist wertvoll - doch Erinnerungen sind trügerisch. Sie verzerren, ergänzen oder lassen Details weg, bis ein falsches Bild entsteht. Dieses Webinar zeigt, warum das Gehirn keine objektive Aufzeichnung liefert und wie diese Verzerrungen Trading-Entscheidungen unbewusst beeinflussen.

Schnell noch Plätze sichern!

Abnehmspritzen – Ist der Hype vorbei? – mit Tim Schäfer

Ist der Hype um Abnehmspritzen wie bei Novo Nordisk und Eli Lilly vorbei – oder stehen wir erst am Anfang einer langfristigen Revolution im Gesundheitswesen? 💉📉

Im heutigen Gespräch mit Tim Schäfer @TimSchaeferMedia sprechen wir über die spannendsten Pharmawerte 2025. Neben den Abnehmspritzen blicken wir auch auf klassische Pharma-Giganten wie Pfizer, Johnson & Johnson, Roche, Novartis, AstraZeneca und GSK. Tim analysiert Übertreibungen, Rücksetzer und langfristige Chancen für Buy-and-Hold-Strategien – mit Fokus auf Dividende, KGV und Krisenresistenz.

💬 Was ist vom Abnehmtrend langfristig zu halten?
💬 Welche Pharma-Aktien sind aktuell unterbewertet?
💬 Was spricht für konservative Dividendenwerte im Gesundheitssektor?

👉🏽 https://bxplus.ch/wall-street-live-mit-tim-schaefer/

Abnehmspritzen – Ist der Hype vorbei? – Wall Street Live mit Tim Schäfer

Mini-Futures auf SMI

Typ Stop-Loss Hebel Symbol
Short 12’974.31 19.37 BP9SUU
Short 13’215.46 13.98 BU9S6U
Short 13’724.19 8.85 B19SNU
SMI-Kurs: 12’465.39 10.11.2025 17:30:00
Long 11’962.62 19.84 SNLBQU
Long 11’690.01 13.82 SSTBSU
Long 11’209.46 8.98 SQZB6U
Die Produktdokumentation, d.h. der Prospekt und das Basisinformationsblatt (BIB), sowie Informationen zu Chancen und Risiken, finden Sie unter: https://keyinvest-ch.ubs.com

Aktien in diesem Artikel

Bullish 36.69 3.45% Bullish